🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Contact: hello@crowdsourcingcures.org

Trial Search

Current Search Criteria:

Intervention: BI 54903 XX

Found 3 matching trials

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers

PHASE1

The objective of the study was to investigate safety, tolerability and phar...

Status

Completed

Location

Multiple Locations

Start Date

2008-06

Trial ID

NCT02221375

Treatments Being Tested

BHT low BHT medium BHT high BI 54903 XX low BI 54903 XX medium 1 BI 54903 XX medium 2 BI 54903 XX high Ciclesonide

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Mono Products of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

PHASE1

The primary objective of this study was to compare the systemic exposure of...

Status

Completed

Location

Multiple Locations

Start Date

2009-04

Trial ID

NCT02222428

Treatments Being Tested

BI 1744 CL/BI 54903 XX FDC BI 54903 XX BI 1744 CL

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

PHASE1

The primary objective of this study was to compare the systemic exposure of...

Status

Completed

Location

Multiple Locations

Start Date

2009-03

Trial ID

NCT02220660

Treatments Being Tested

BI 1744 CL BI 54903 XX BI 1744 CL + BI 54903 XX FDC Placebo

Previous Next